46
Participants
Start Date
October 1, 2020
Primary Completion Date
April 1, 2021
Study Completion Date
April 17, 2021
Temporarily holding the RAAS inhibitor [intervention]
Temporarily holding the RAAS inhibitor. Among participants who will be randomized to the intervention arm, a possible guideline-directed alternative to anti-hypertensive medication alternatives will be provided to the treating physician team.
RAAS inhibitor [continued standard of care]
No intervention, Continuation RAAS inhibitor \[continued standard of care\].
Muhc-Rimuhc, Montreal
Jewish General Hospital (Montreal, Quebec, Canada)
UNKNOWN
Montreal General Hospital (Montreal, Quebec, Canada)
UNKNOWN
Université de Lorraine, Centre d'Investigation Clinique- Plurithématique Inserm
UNKNOWN
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER